Shanghai (1)

Bone Cancer Metastatic (1)

Cancer of Unknown Primary (1)

Chemotherapy Effect (1)

Gene Mutation-Related Cancer (1)

Immune Evasion, Tumor (1)

Tislelizumab (1)

Recruiting (1)

phase 2 (1)

Wei Xu (1)

tislelizumab plus chemotherapy (1)

drug (1)

Other (1)

Interventional (1)

bone cancer metastatic

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Feb 6, 2022